Review: Cell Dynamics in Malignant Pleural Effusions

被引:18
|
作者
Giarnieri, Enrico [1 ]
Bellipanni, Gianfranco [2 ]
Macaluso, Marcella [2 ]
Mancini, Rita [1 ]
Holstein, Adam Carl [2 ]
Milanese, Carla [2 ]
Giovagnoli, Maria Rosaria [1 ]
Giordano, Antonio [2 ,3 ,4 ]
Russo, Giuseppe [2 ]
机构
[1] Univ Roma La Sapienza, Dept Clin & Mol Med, Fac Med & Psychol, I-00189 Rome, Italy
[2] Temple Univ, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, Philadelphia, PA 19122 USA
[3] Canc Res Ctr, Pascale Fdn Natl Canc Inst, INT CROM, Mercogliano, AV, Italy
[4] Univ Siena, Dept Med & Surg Sci & Neurosci, I-53100 Siena, Italy
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; ENDOTHELIAL GROWTH-FACTOR; CADHERIN GENE-EXPRESSION; BREAST-CANCER CELLS; TUMOR PROGRESSION; MIR-200; FAMILY; LUNG ADENOCARCINOMA; TGF-BETA; PANCREATIC-CANCER;
D O I
10.1002/jcp.24806
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Malignant pleural effusions (MPEs) are a common manifestation found in patients with lung cancer. After cytological and histological confirmation of malignancy, talc pleurodesis still remains the treatment of choice in patients with MPEs resistant to chemotherapy. Despite this, primary challenges include reduced quality of life and life expectancy in general. Therefore, a better understanding of the cell biology of MPEs, along with improvements in treatment is greatly needed. It has recently been demonstrated that MPEs may represent an excellent source for identification of molecular mechanisms within the tumor and its environment. The present review summarizes the current understanding of MPEs cells and tumor microenvironment, and particularly focuses on dissecting the cross-talk between MPEs and epithelial to mesenchymal transition (EMT), inflammation and cancer stem cells. (C) 2014 Wiley Periodicals, Inc.
引用
下载
收藏
页码:272 / 277
页数:6
相关论文
共 50 条
  • [21] Management of malignant pleural effusions
    Dipper, Alexandra
    Bhatnagar, Rahul
    Maskell, Nick
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 341 - 345
  • [22] TREATMENT FOR MALIGNANT PLEURAL EFFUSIONS
    WALLACH, HW
    CHEST, 1976, 70 (03) : 408 - 409
  • [23] THORACOSCOPY IN MALIGNANT PLEURAL EFFUSIONS
    BOUTIN, C
    VIALLAT, JR
    CARGNINO, P
    FARISSE, P
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1981, 124 (05): : 588 - 592
  • [24] Phenotyping malignant pleural effusions
    Lui, Macy M. S.
    Fitzgerald, Deirdre B.
    Lee, Y. C. Gary
    CURRENT OPINION IN PULMONARY MEDICINE, 2016, 22 (04) : 350 - 355
  • [25] Management of malignant pleural effusions
    David Hsia
    Ali I. Musani
    Current Respiratory Care Reports, 2012, 1 (2): : 73 - 81
  • [26] Approach to Malignant Pleural Effusions
    Goldstraw, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1624 - S1625
  • [27] Readmissions for Malignant Pleural Effusions
    Yang, T. S.
    Hsia, D. W.
    Chang, D. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [28] MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    RUCKDESCHEL, JC
    SEMINARS IN ONCOLOGY, 1995, 22 (02) : 58 - 63
  • [29] The palliation of malignant pleural effusions
    Bhatnagar, Rahul
    Rahman, Najib M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (01) : 4 - 5
  • [30] Management of malignant pleural effusions
    Mateen H. Uzbeck
    Francisco A. Almeida
    Mona G. Sarkiss
    Rodolfo C. Morice
    Carlos A. Jimenez
    Georgie A. Eapen
    Marcus P. Kennedy
    Advances in Therapy, 2010, 27 : 334 - 347